These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 15754797)

  • 1. Recent developments in tissue-type imaging (TTI) for planning and monitoring treatment of prostate cancer.
    Feleppa EJ; Porter CR; Ketterling J; Lee P; Dasgupta S; Urban S; Kalisz A
    Ultrason Imaging; 2004 Jul; 26(3):163-72. PubMed ID: 15754797
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Spectrum-analysis and neural networks for imaging to detect and treat prostate cancer.
    Feleppa EJ; Ennis RD; Schiff PB; Wuu CS; Kalisz A; Ketterling J; Urban S; Liu T; Fair WR; Porter CR; Gillespie JR
    Ultrason Imaging; 2001 Jul; 23(3):135-46. PubMed ID: 11958585
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An artificial neural network for prostate cancer staging when serum prostate specific antigen is 10 ng./ml. or less.
    Zlotta AR; Remzi M; Snow PB; Schulman CC; Marberger M; Djavan B
    J Urol; 2003 May; 169(5):1724-8. PubMed ID: 12686818
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Progress in Two-Dimensional and Three-Dimensional Ultrasonic Tissue-Type Imaging of the Prostate Based on Spectrum Analysis and Nonlinear Classifiers.
    Feleppa EJ; Fair WR; Tsai H; Porter C; Balaji KC; Liu T; Kalisz A; Lizzi FL; Rosado A; Manolakis D; Gnadt W; Reuter V; Miltner MJ
    Mol Urol; 1999; 3(3):303-310. PubMed ID: 10851337
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of advanced 2 and 3-dimensional ultrasound for detecting prostate cancer.
    Balaji KC; Fair WR; Feleppa EJ; Porter CR; Tsai H; Liu T; Kalisz A; Urban S; Gillespie J
    J Urol; 2002 Dec; 168(6):2422-5. PubMed ID: 12441931
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preoperative neural network using combined magnetic resonance imaging variables, prostate-specific antigen, and Gleason score to predict positive surgical margins.
    Poulakis V; Witzsch U; de Vries R; Emmerlich V; Meves M; Altmannsberger HM; Becht E
    Urology; 2004 Sep; 64(3):516-21. PubMed ID: 15351582
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Three-dimensional ultrasound analyses of the prostate.
    Feleppa EJ; Fair WR; Liu T; Kalisz A; Balaji KC; Porter CR; Tsai H; Reuter V; Gnadt W; Miltner MJ
    Mol Urol; 2000; 4(3):133-9;discussion 141. PubMed ID: 11062367
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preoperative neural network using combined magnetic resonance imaging variables, prostate specific antigen, and Gleason score to predict prostate cancer recurrence after radical prostatectomy.
    Poulakis V; Witzsch U; de Vries R; Emmerlich V; Meves M; Altmannsberger HM; Becht E
    Eur Urol; 2004 Nov; 46(5):571-8. PubMed ID: 15474265
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ultrasonic tissue-type imaging of the prostate: implications for biopsy and treatment guidance.
    Feleppa EJ
    Cancer Biomark; 2008; 4(4-5):201-12. PubMed ID: 18957711
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ultrasonic spectrum-analysis and neural-network classification as a basis for ultrasonic imaging to target brachytherapy of prostate cancer.
    Feleppa EJ; Ennis RD; Schiff PB; Wuu CS; Kalisz A; Ketterling J; Urban S; Liu T; Fair WR; Porter CR; Gillespie JR
    Brachytherapy; 2002; 1(1):48-53. PubMed ID: 15062187
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development, validation, and head-to-head comparison of logistic regression-based nomograms and artificial neural network models predicting prostate cancer on initial extended biopsy.
    Kawakami S; Numao N; Okubo Y; Koga F; Yamamoto S; Saito K; Fujii Y; Yonese J; Masuda H; Kihara K; Fukui I
    Eur Urol; 2008 Sep; 54(3):601-11. PubMed ID: 18207312
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Critical evaluation of magnetic resonance imaging targeted, transrectal ultrasound guided transperineal fusion biopsy for detection of prostate cancer.
    Kuru TH; Roethke MC; Seidenader J; Simpfendörfer T; Boxler S; Alammar K; Rieker P; Popeneciu VI; Roth W; Pahernik S; Schlemmer HP; Hohenfellner M; Hadaschik BA
    J Urol; 2013 Oct; 190(4):1380-6. PubMed ID: 23608676
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preoperative neural network using combined magnetic resonance imaging variables, prostate-specific antigen, and gleason score for predicting prostate cancer biochemical recurrence after radical prostatectomy.
    Poulakis V; Witzsch U; de Vries R; Emmerlich V; Meves M; Altmannsberger HM; Becht E
    Urology; 2004 Dec; 64(6):1165-70. PubMed ID: 15596191
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endorectal magnetic resonance imaging and magnetic resonance spectroscopy to monitor the prostate for residual disease or local cancer recurrence after transrectal high-intensity focused ultrasound.
    Cirillo S; Petracchini M; D'Urso L; Dellamonica P; Illing R; Regge D; Muto G
    BJU Int; 2008 Aug; 102(4):452-8. PubMed ID: 18476973
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The use of artificial neural network analysis to improve the predictive accuracy of prostate biopsy in the Japanese population.
    Matsui Y; Utsunomiya N; Ichioka K; Ueda N; Yoshimura K; Terai A; Arai Y
    Jpn J Clin Oncol; 2004 Oct; 34(10):602-7. PubMed ID: 15591458
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of Diffusion Kurtosis Imaging Versus Standard Diffusion Imaging for Detection and Grading of Peripheral Zone Prostate Cancer.
    Roethke MC; Kuder TA; Kuru TH; Fenchel M; Hadaschik BA; Laun FB; Schlemmer HP; Stieltjes B
    Invest Radiol; 2015 Aug; 50(8):483-9. PubMed ID: 25867657
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multiparametric magnetic resonance imaging of the prostate can improve the predictive value of the urinary prostate cancer antigen 3 test in patients with elevated prostate-specific antigen levels and a previous negative biopsy.
    Sciarra A; Panebianco V; Cattarino S; Busetto GM; De Berardinis E; Ciccariello M; Gentile V; Salciccia S
    BJU Int; 2012 Dec; 110(11):1661-5. PubMed ID: 22564540
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outcome prediction for prostate cancer detection rate with artificial neural network (ANN) in daily routine.
    Ecke TH; Bartel P; Hallmann S; Koch S; Ruttloff J; Cammann H; Lein M; Schrader M; Miller K; Stephan C
    Urol Oncol; 2012; 30(2):139-44. PubMed ID: 20363164
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improved prostate cancer detection with a human kallikrein 11 and percentage free PSA-based artificial neural network.
    Stephan C; Meyer HA; Cammann H; Nakamura T; Diamandis EP; Jung K
    Biol Chem; 2006 Jun; 387(6):801-5. PubMed ID: 16800743
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Machine learning for improved pathological staging of prostate cancer: a performance comparison on a range of classifiers.
    Regnier-Coudert O; McCall J; Lothian R; Lam T; McClinton S; N'dow J
    Artif Intell Med; 2012 May; 55(1):25-35. PubMed ID: 22206941
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.